Northern Trust Corp Sells 94,812 Shares of Stevanato Group S.p.A. (NYSE:STVN)

Northern Trust Corp trimmed its holdings in Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 55.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 74,887 shares of the company's stock after selling 94,812 shares during the period. Northern Trust Corp's holdings in Stevanato Group were worth $1,632,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. SG Americas Securities LLC lifted its holdings in Stevanato Group by 18.2% during the 4th quarter. SG Americas Securities LLC now owns 15,546 shares of the company's stock worth $339,000 after purchasing an additional 2,389 shares during the last quarter. Jennison Associates LLC acquired a new stake in Stevanato Group during the 4th quarter worth approximately $20,239,000. Conestoga Capital Advisors LLC lifted its holdings in Stevanato Group by 5.3% during the 4th quarter. Conestoga Capital Advisors LLC now owns 8,082,996 shares of the company's stock worth $176,128,000 after purchasing an additional 407,086 shares during the last quarter. Truist Financial Corp lifted its holdings in Stevanato Group by 4.2% during the 4th quarter. Truist Financial Corp now owns 26,900 shares of the company's stock worth $586,000 after purchasing an additional 1,073 shares during the last quarter. Finally, Peregrine Capital Management LLC lifted its holdings in Stevanato Group by 1.9% during the 4th quarter. Peregrine Capital Management LLC now owns 366,078 shares of the company's stock worth $7,977,000 after purchasing an additional 6,661 shares during the last quarter.

Stevanato Group Price Performance

NYSE STVN traded down €0.28 ($0.31) during midday trading on Thursday, hitting €22.91 ($25.74). The company had a trading volume of 181,353 shares, compared to its average volume of 339,494. The company has a market capitalization of $6.94 billion, a PE ratio of 48.74, a P/E/G ratio of 7.18 and a beta of 0.51. The company has a current ratio of 1.81, a quick ratio of 1.21 and a debt-to-equity ratio of 0.22. The firm has a 50-day moving average price of €21.77 and a 200-day moving average price of €21.33. Stevanato Group S.p.A. has a twelve month low of €16.56 ($18.61) and a twelve month high of €25.75 ($28.93).

Stevanato Group (NYSE:STVN - Get Free Report) last announced its quarterly earnings data on Thursday, March 6th. The company reported €0.20 ($0.22) earnings per share for the quarter, meeting the consensus estimate of €0.20 ($0.22). The firm had revenue of €352.68 million during the quarter, compared to analysts' expectations of €346.26 million. Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. As a group, analysts anticipate that Stevanato Group S.p.A. will post 0.5 earnings per share for the current fiscal year.

Stevanato Group Increases Dividend

The firm also recently declared an annual dividend, which will be paid on Thursday, July 17th. Stockholders of record on Thursday, June 5th will be paid a $0.0613 dividend. This is a positive change from Stevanato Group's previous annual dividend of $0.05. The ex-dividend date of this dividend is Thursday, June 5th. This represents a dividend yield of 0.3%. Stevanato Group's dividend payout ratio (DPR) is presently 11.76%.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the company. Stephens raised Stevanato Group to a "strong-buy" rating in a report on Monday, April 21st. UBS Group dropped their price target on Stevanato Group from $24.00 to $23.50 and set a "neutral" rating for the company in a report on Friday, March 7th. Finally, William Blair reissued an "outperform" rating on shares of Stevanato Group in a report on Friday, March 7th. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, Stevanato Group currently has an average rating of "Moderate Buy" and a consensus target price of €25.70 ($28.88).

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.